- Culture Based Tests
- Mantoux Test (TST)
- Interferon Gamma Release Analysis (IGRA)
- Nucleic Acid Testing
- Sear Microscopy
- Serological Tests
Tuberculosis Testing Market size was valued at USD 3.02 billion in 2022 and is poised to grow at a CAGR of 4.5% from 2023 to 2029. Tuberculosis is a bacterial infectious disease caused by Mycobacterium tuberculosis (MTB). Tuberculosis spreads through air and direct contact with the infected sputum. Tuberculosis usually affects lungs. But it can affect any other parts of the body. Tuberculosis patient generally experiences symptoms such as cough, chills, fever, fatigue, loss of weight and others. TB infecting bones can lead to joint destruction or spinal pain. The most common diagnostic test used for TB is skin test, but it is not fully accurate. There are many tuberculosis tests are available such as bloodstream test, sputum tests, and Chest X-rays. The tuberculosis testing market is consolidated with the presence of strong market key players involving in development and marketing of the tuberculosis tests. Companies adopting the strategies such as mergers and acquisitions to strengthen their market position and expand their global reach. For instance, in October 2017, Abbot Laboratories has acquired Alere Inc., to become a leading market player in point of care testing and advance its geographical reach. Furthermore, market layers also developing new testing technologies and novel products to increase their market share. For instance, in Feb 2012, Quanterix Corporation collaborated with the Forsyth Institute and Beth Israel Deaconess Medical Center (BIDMC) to develop the fast and simple test for accurate diagnosis of tuberculosis.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Primary drivers for the global tuberculosis testing market include the rise in the disease prevalence worldwide. In addition, technological advancements in tuberculosis testing such as advent of test kits and point of care products are expected to boost the global tuberculosis testing market over the forecast period. Furthermore, government initiatives for early detection and of tuberculosis coupled with an increase in adaptation of the point of care products for tuberculosis diagnosis are expected to boost the market growth over the forecast period. However, R&D cost for the development of the novel testing procedures for TB expected to hamper the market growth over the coming years.
2023 is the base year and 2029 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Executive Summary |
2. Global Tuberculosis Testing Market Introduction |
2.1.Global Tuberculosis Testing Market - Taxonomy |
2.2.Global Tuberculosis Testing Market - Definitions |
2.2.1.Test Type |
2.2.2.End User |
2.2.3.Region |
3. Global Tuberculosis Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Tuberculosis Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Tuberculosis Testing Market By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Culture Based Tests |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Mantoux Test (TST) |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Interferon Gamma Release Analysis (IGRA) |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Nucleic Acid Testing |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Sear Microscopy |
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Serological Tests |
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. Global Tuberculosis Testing Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Hospitals |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Diagnostic Centres |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Tuberculosis Testing Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. North America Tuberculosis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Culture Based Tests |
8.1.2.Mantoux Test (TST) |
8.1.3.Interferon Gamma Release Analysis (IGRA) |
8.1.4.Nucleic Acid Testing |
8.1.5.Sear Microscopy |
8.1.6.Serological Tests |
8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Hospitals |
8.2.2.Diagnostic Centres |
8.2.3.Others |
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9. Europe Tuberculosis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Culture Based Tests |
9.1.2.Mantoux Test (TST) |
9.1.3.Interferon Gamma Release Analysis (IGRA) |
9.1.4.Nucleic Acid Testing |
9.1.5.Sear Microscopy |
9.1.6.Serological Tests |
9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Hospitals |
9.2.2.Diagnostic Centres |
9.2.3.Others |
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
10. Asia Pacific (APAC) Tuberculosis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Culture Based Tests |
10.1.2.Mantoux Test (TST) |
10.1.3.Interferon Gamma Release Analysis (IGRA) |
10.1.4.Nucleic Acid Testing |
10.1.5.Sear Microscopy |
10.1.6.Serological Tests |
10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Hospitals |
10.2.2.Diagnostic Centres |
10.2.3.Others |
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11. Middle East and Africa (MEA) Tuberculosis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Culture Based Tests |
11.1.2.Mantoux Test (TST) |
11.1.3.Interferon Gamma Release Analysis (IGRA) |
11.1.4.Nucleic Acid Testing |
11.1.5.Sear Microscopy |
11.1.6.Serological Tests |
11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Hospitals |
11.2.2.Diagnostic Centres |
11.2.3.Others |
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12. Latin America Tuberculosis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Culture Based Tests |
12.1.2.Mantoux Test (TST) |
12.1.3.Interferon Gamma Release Analysis (IGRA) |
12.1.4.Nucleic Acid Testing |
12.1.5.Sear Microscopy |
12.1.6.Serological Tests |
12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Hospitals |
12.2.2.Diagnostic Centres |
12.2.3.Others |
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Hologic, Inc. |
13.2.2.Thermo Fisher Scientific, Inc. |
13.2.3.Becton, Dickinson and Company |
13.2.4.Abbott Laboratories |
13.2.5.bioMerieux SA |
13.2.6.Hoffmann-La Roche AG |
13.2.7.Cepheid |
13.2.8.Sanofi S.A. |
14. Research Methodology |
15. Appendix and Abbreviations |